Stay updated on Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study page now shows revision v3.5.5 instead of v3.5.4, signaling a recent update to the record.
    Difference
    0.1%
    Check dated 2026-06-05T09:40:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page version has been updated from v3.5.3 to v3.5.4, indicating a software update to the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:24.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3 on the study documents listed on the page, representing a newer version of the protocol/document referenced.
    Difference
    0.1%
    Check dated 2026-04-30T16:59:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision tag now shows v3.5.2 instead of v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:59:03.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 entry and removed v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-18T19:08:29.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No study data or user-facing content changes.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:35.000Z thumbnail image

Stay in the know with updates to Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.